Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids.

The research article focuses on a study conducted to determine the levels of cartilage oligomeric matrix protein (COMP) in the synovial fluids of horses both with and without joint disease. It also examines how COMP degradation relates to matrix metalloproteinase (MMP) activity. The findings suggest that the pattern and concentration of COMP could be effective in monitoring joint disease, and that a higher MMP activity may cause COMP degradation in diseased joints.

Study Objective and Methodology

• The aim of this study was to analyze the presence and concentration of cartilage oligomeric matrix protein or COMP in the synovial fluids of horses, both healthy and affected by joint disease. The researchers also aimed to understand the relationship between COMP degradation and matrix metalloproteinase (MMP) activity in the synovial fluids.
• To accomplish this, the scientists developed an inhibition ELISA (enzyme-linked immunosorbent assay), a common laboratory technique used to measure the concentration of substances such as proteins in biological samples. The ELISA was designed using COMP antigen prepared from equine articular cartilage and a specific type of antibody (12C4) that was raised against human COMP.
• The concentration of COMP in the synovial fluids from both healthy and diseased horse joints was then measured. At the same time, the MMP activities in the same synovial fluids were evaluated through a gelatin degradation ELISA. Additionally, the COMP fragments were examined qualitatively using a technique called Western blotting.

Results

• The COMP inhibition ELISA was found to be reliable at concentrations of equine COMP ranging from 62.5 to 2000 ng/ml.
• The studies revealed that COMP values in the joint fluids of horses with both aseptic and septic joint disease were significantly lower than those in healthy horses.
• Furthermore, the molecular sizes of COMP varied between healthy and diseased synovial fluids, with more fragments being observed in diseased fluids.
• The MMP activity recorded in the synovial fluids of horses with both types of joint disease was significantly higher than in healthy horses. This suggested a negative correlation between COMP levels and gelatinase or MMP activity.

Conclusions

• From the results obtained, the researchers concluded that the pattern of COMP fragments and the absolute concentration of COMP could potentially be useful markers for monitoring joint disease in horses.
• Furthermore, it was posited that the degradation of COMP observed in the synovial fluids of horses suffering from advanced joint disease may be attributed to increased MMP activity.